Year 2023 / Volume 30 / Number 3

PDF HTML

Avances en Dolor

A road trip to chemotherapy-induced neuropathic pain

Rev. Soc. Esp. Dolor. 2023; 30(3): 155-156 / DOI: 10.20986/resed.2023.4110/2023

Enrique J. Cobos






Complete Article

New comment

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No comments in this article

References

1. Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol. 2020;38(28):3325-48.
DOI: 10.1200/JCO.20.01399
2. Marcotti A, Fernández-Trillo J, González A, Vizcaíno-Escoto M, Ros-Arlanzón P, Romero L, et al. TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy. Brain. 2023;146(2):475-91.
DOI: 10.1093/brain/awac273
3. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461-70.
DOI: 10.1016/j.pain.2014.09.020
4. Ruiz-Cantero MC, González-Cano R, Tejada MÁ, Santos-Caballero M, Perazzoli G, Nieto FR, et al. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain. Pharmacol Res. 2021;163:105339.
DOI: 10.1016/j.phrs.2020.105339
5. Nieto FR, Cendán CM, Sánchez-Fernández C, Cobos EJ, Entrena JM, Tejada MA, et al. Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice. J Pain. 2012;13(11):1107-21.
DOI: 10.1016/j.jpain.2012.08.006
6. Paniagua N, Goicoechea C, Abalo R, López-Miranda V, Vela JM, Merlos M, et al. May a sigma-1 antagonist improve neuropathic signs induced by cisplatin and vincristine in rats? Eur J Pain. 2019;23(3):603-20.
DOI: 10.1002/ejp.1333
7. Gris G, Portillo-Salido E, Aubel B, Darbaky Y, Deseure K, Vela JM, et al. The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats. Sci Rep. 2016;6:24591.
DOI: 10.1038/srep24591
8. Ruiz-Cantero MC, Cortés-Montero E, Jain A, Montilla-García Á, Bravo-Caparrós I, Shim J, et al. The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors. Br J Pharmacol. 2023;180(8):1148-67.
DOI: 10.1111/bph.16003
9. Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, et al. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial. Neurotherapeutics. 2018;15(1):178-89.
DOI: 10.1007/s13311-017-0572-5

Related articles

Citation tools

Cobos E. A road trip to chemotherapy-induced neuropathic pain. Rev Soc Esp Dolor 2023; 30(3): 155-156 / DOI: 1020986/resed20234110/2023


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 9975 visits.
This article has been downloaded 1 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Accepted: 10/10/2023

Online First: 10/10/2023

Published: 22/12/2023


Share

This article hasn't been rated yet.
Reader rating:
Rate this article:
Send by e-mail
© 2025 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexed in:
Legal Notice